CTNM

Contineum Therapeutics
CTNM

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$18.67
68% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Baird
Baird
Joel Beatty
100% 1-yr CTNM win rate
24 Nov ‘25 10 days ago
RBC Capital
RBC Capital
Brian Abrahams
33% 1-yr CTNM win rate
21 Nov ‘25 13 days ago
Leerink Partners
Leerink Partners
Faisal Khurshid
100% 1-yr CTNM win rate
25 Sep ‘25 2 months ago